Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 21, 2016

Primary Completion Date

October 12, 2017

Study Completion Date

November 8, 2019

Conditions
Cholestasis
Interventions
DRUG

Intralipid 20% I.V. Fat Emulsion

Trial Locations (5)

32601

University of Florida, Gainesville

48109

University of Michigan, Ann Arbor

80045

University of Colorado/Children's Hospital Colorado, Aurora

84132

Primary Children's Hospital, Salt Lake City

98105

Seattle Children's Hospital, Seattle

All Listed Sponsors
collaborator

Seattle Children's Hospital

OTHER

collaborator

University of Florida

OTHER

collaborator

Primary Children's Hospital

OTHER

collaborator

University of Colorado, Denver

OTHER

lead

University of Michigan

OTHER

NCT02357576 - Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD | Biotech Hunter | Biotech Hunter